Mumbai: Informa Markets in India, India’s leading B2B exhibitions organiser, has made a ₹50 lakh CSR donation of critical diagnostic equipment to strengthen public healthcare diagnostics in Mumbai. The initiative is expected to generate cumulative annual savings of over ₹100 crore for underserved patients by significantly reducing the cost of critical diagnostic tests. The programme demonstrates how strategic infrastructure investment can create exponential social impact.
As part of the initiative, Informa Markets in India donated a chemiluminescence immunoassay (CLIA) analyser to Dr. R. N. Cooper Municipal General Hospital, also known as Hinduhridaysamrat Balasaheb Thackeray (HBT) Medical College & Hospital, a major tertiary-care government hospital serving Mumbai’s western suburbs.
The CSR programme was implemented in partnership with Child Help Foundation, a pan-India, child-centric NGO with a strong on-ground presence and a focus on health, education, nutrition, and community-based interventions.
Transforming Access to High-Quality Diagnostics
The CLIA analyser is a highly sensitive, automated diagnostic system used to detect low-concentration analytes such as hormones, tumour markers, infectious disease indicators, and reproductive health markers. It offers high accuracy (CV <8 per cent), rapid turnaround time, and high throughput—making it particularly suitable for high-volume public hospitals.
In private laboratories, CLIA-based tests typically cost between ₹1,200 and ₹2,500 per test. With the new equipment in place, Dr R. N. Cooper Hospital can offer the same tests at ₹150–₹200 per test, representing an 85-90 per cent cost reduction for patients.
Based on estimated patient volumes, the initiative is projected to result in ₹120–₹240 crore in annual cost savings for underserved communities. This positions the ₹50 lakh CSR investment as a high-impact intervention with significant social return on investment.
Strengthening Public Healthcare Infrastructure
Dr. R. N. Cooper Municipal General Hospital is a major tertiary care facility operated by the Brihanmumbai Municipal Corporation (BMC). It serves as a key emergency, trauma, and referral hospital for the Juhu–Vile Parle region and functions as a teaching hospital under HBT Medical College.
The hospital offers multi-speciality care across departments, including General Medicine, Surgery, Paediatrics, Obstetrics & Gynaecology, Orthopaedics, Psychiatry, Pulmonary Medicine, and more, supported by specialised units such as a NICU, blood bank, burns ward, and diagnostic services.
The addition of the CLIA analyser is expected to reduce diagnostic wait times, improve clinical decision-making, and enable earlier intervention for patients who may otherwise defer or forgo testing due to cost constraints.


